Lung Cancer News and Research

Latest Lung Cancer News and Research

Patients can now swallow pill-sized, disposable cameras to help diagnose diseases of the esophagus

Patients can now swallow pill-sized, disposable cameras to help gastroenterologists diagnose and evaluate diseases of the esophagus, or swallowing tube. This new diagnostic tool is a further modification of capsule endoscopy, which has been used clinically since late 2001 to examine the small intestines.

15 Mar 2005

Bevacizumab (Avastin) in combination with standard chemotherapy helps advanced lung cancer sufferers

Preliminary results from a large, randomized clinical trial for patients with previously untreated advanced non-squamous, non-small cell lung cancer show that those patients who received bevacizumab (AvastinTM) in combination with standard chemotherapy lived longer than patients who received the same chemotherapy without bevacizumab.

15 Mar 2005

Good results in new lung cancer treatment

Interim analysis of a Phase III study of Avastin (bevacizumab) with paclitaxel and carboplatin chemotherapies in first-line non-squamous, non-small cell lung cancer (NSCLC) met its primary goal of improving overall survival, or a reduction in the risk of death, compared to chemotherapy alone.

15 Mar 2005

£800,000 to boost research into fighting viruses

A team of University of Glasgow scientists have received a grant of £800,000 from the Wellcome Trust to research a mechanism that blocks a critical step in the replication cycle of retroviruses. In the long term, the research could lead to the design of new therapeutic strategies or drugs against retroviruses, which cause diseases such as AIDS and certain leukemias.

14 Mar 2005

Molecule called DJ-1 is likely to be involved in the generation of human tumors

Scientists have discovered that a molecule called DJ-1 is likely to be involved in the generation of human tumors through negative regulation of the well-known tumor suppressor, PTEN. The research, published in the March issue of Cancer Cell, has important implications for determining the prognosis of some human cancers, and may prove to be a suitable target for cancer therapy.

14 Mar 2005

Association between prolonged residential radon exposure and lung cancer risk

Two University of Iowa researchers were part of a large multi-center study that provides compelling direct evidence of an association between prolonged residential radon exposure and lung cancer risk.

14 Mar 2005

Finding may open new horizons for understanding the initiation of chemically induced cancers

A team from the chemistry and biology departments of New York University, in collaboration with Memorial Sloan Kettering Cancer Center (MSKCC), has uncovered a conformational switch - a change in shape in a carcinogen-damaged DNA site - in tumor suppressor genes altered by a known cancer-causing chemical found in cigarette smoke.

9 Mar 2005

Combining PET and CT scans leads to more accurate radiation therapy for lung cancer patients

Using Positron Emission Tomography in addition to Computed Tomography can reduce the amount of radiation exposure to normal tissue in some lung cancer patients

8 Mar 2005

Lung cancer rates among men are on the decline

Results of the most comprehensive analysis to date of the impact of gender differences in lung cancer incidence in the United States indicate that lung cancer rates among men are on the decline, while the rate in women remains steady.

8 Mar 2005

Underhand methods used to challenge secondhand smoke's link to infant death risk

The link between secondhand smoke and sudden infant death has been discredited in the last few years in scientific articles paid for and influenced by cigarette manufacturers, according to a new study of once-secret industry documents.

7 Mar 2005

ViroLogic and AstraZeneca to conduct Iressa biomarker study

ViroLogic announced today that it had entered into an agreement with AstraZeneca to conduct a cancer biomarker study with application to Iressa, AstraZeneca's selective epidermal growth factor receptor kinase inhibitor.

7 Mar 2005

Important advance in our understanding of colorectal cancer

An international team of medical scientists has made an important advance in our understanding of the second most fatal form of cancer in the industrialized world. Professor Jeremy R. Jass, who holds a Canada Research Chair in Gastrointestinal Pathology at McGill University in Montreal

3 Mar 2005

Researchers identify first known mutation to occur in lung cancer patients who have never smoked

Dr.Adi Gazdar, professor of pathology in the Nancy B. and Jake L. Hamon Center for Therapeutic Oncology Research and senior author of the study in today's issue of the Journal of the National Cancer Institute, explains that the findings may show why certain lung cancer patients respond dramatically to a specific form of targeted therapy while others have little or no response.

2 Mar 2005

Lung Cancer News and Research

Latest Lung Cancer News and Research

Patients can now swallow pill-sized, disposable cameras to help diagnose diseases of the esophagus

Bevacizumab (Avastin) in combination with standard chemotherapy helps advanced lung cancer sufferers

Good results in new lung cancer treatment

£800,000 to boost research into fighting viruses

Molecule called DJ-1 is likely to be involved in the generation of human tumors

Association between prolonged residential radon exposure and lung cancer risk

Finding may open new horizons for understanding the initiation of chemically induced cancers

Combining PET and CT scans leads to more accurate radiation therapy for lung cancer patients

Lung cancer rates among men are on the decline

Underhand methods used to challenge secondhand smoke's link to infant death risk

ViroLogic and AstraZeneca to conduct Iressa biomarker study

Important advance in our understanding of colorectal cancer

Researchers identify first known mutation to occur in lung cancer patients who have never smoked

Molecule from South American tree Quillaja, helps battle disease

Study describes the first known mutation to occur in lung cancer patients who have never smoked

Framework Convention on Tobacco Control (WHO FCTC) entered into force today

Why some lung cancers stop responding to the drugs erlotinib (Tarceva) and gefitinib (Iressa)

Deaths from mesothelioma will peak within ten years in the UK

$9.8 million grant to research cancer risks from space radiation

Blocking estrogen may be vitally important to improving survival from lung cancer

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Lung Cancer News and Research

Latest Lung Cancer News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in